Combating Endocrine Resistance in Breast Cancer With Novel Agents, Combinations
January 12th 2018This video reviews endocrine resistance mediated by CDK4/6, FGFR, and PI3K in HR-positive breast cancer, and highlights the latest efforts to inhibit these pathways with novel targeted drugs and combinations.